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Abstract
Background: Development of longer term stroke rehabilitation services is limited by lack of evidence of effectiveness
for specific interventions and service models. We describe the protocol for a multicentre randomised controlled trial
which is evaluating an extended stroke rehabilitation service. The extended service commences when routine
‘organised stroke care’ (stroke unit and early supported discharge (ESD)) ends.
Methods/design: This study is a multicentre randomised controlled trial with health economic and process evaluations.
It is set within NHS stroke services which provide ESD. Participants are adults who have experienced a new stroke (and
carer if appropriate), discharged from hospital under the care of an ESD team.
The intervention group receives an extended stroke rehabilitation service provided for 18 months following completion
of ESD. The extended rehabilitation service involves regular contact with a senior ESD team member who leads and
coordinates further rehabilitation. Contact is usually by telephone. The control group receives usual stroke care post-ESD.
Usual care may involve referral of patients to a range of rehabilitation services upon completion of ESD in accordance
with local clinical practice. Randomisation is via a central independent web-based service.
The primary outcome is extended activities of daily living (Nottingham Extended Activities of Daily Living Scale) at
24 months post-randomisation. Secondary outcomes (at 12 and 24 months post-randomisation) are health status, quality
of life, mood and experience of services for patients, and quality of life, experience of services and carer stress for carers.
Resource use and adverse events are also collected. Outcomes are undertaken by a blinded assessor.
Implementation and delivery of the extended stroke rehabilitation service will also be described. Semi-structured
interviews will be conducted with a subsample of participants and staff to gain insight into perceptions and
experiences of rehabilitation services delivered or received.
Allowing for 25% attrition, 510 participants are needed to provide 90% power to detect a difference in mean
Nottingham Extended Activities of Daily Living Scale score of 6 with a 5% significance level.
Discussion: The provision of longer term support for stroke survivors is currently limited. The results from this
trial will inform future stroke service planning and configuration.
Trial registration: This trial was registered with ISRCTN (identifier: ISRCTN45203373) on 9 August 2012.
Keywords: Stroke, Rehabilitation, Early supported discharge, Community services, Health economics, Randomised
controlled trial
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Background
There are approximately 300,000 disabled stroke sur-
vivors in the UK [1]. Although one third of patients
remain disabled 12 months after acute stroke, the longer
term provision of stroke rehabilitation is sparse. Input
from a therapist or nurse with specialist expertise in stroke
rehabilitation is rare beyond 6 months post-discharge.
Stroke patients and their informal carers are frequently
disappointed and frustrated that longer term rehabilitation
is not more widely available, and the UK Stroke Survivor
Needs Survey reported that nearly half of stroke survivors
experience unmet needs in the longer term [2].
Stroke units and early supported discharge (ESD) ser-
vices are effective ways to improve patient outcomes and
the quality of care following stroke [3,4]. These services
are referred to as ‘organised stroke care’, and their key
features are multidisciplinary stroke specialist expertise
and coordination of care [5,6]. In contrast, there is no
clear evidence of the clinical and cost effectiveness of lon-
ger term rehabilitation following stroke [7]. A Cochrane
review of therapy-based rehabilitation services for patients
living at home more than one year after stroke concluded
that it was unclear whether rehabilitation provided after
one year can improve recovery [8]. However, therapy-
based rehabilitation services for stroke patients at home
provided soon after discharge have been shown to be
effective [9].
ESD services offer patients the opportunity to con-
tinue rehabilitation in their own home following a
period of stroke unit care. ESD provided by a specialist
multidisciplinary team leads to better clinical outcomes,
increased satisfaction with care and reduced NHS costs
[3]. ESD is a core component of an evidence-based stroke
service, and it is the current ‘gold standard’ for an early
community rehabilitation service for stroke patients with
ongoing rehabilitation needs who are discharged to their
own homes [10]. Typically, an ESD team becomes in-
volved with discharge planning with patient, family and
stroke unit staff at an early stage of admission. Prior to
discharge from hospital, a member of the team may
undertake a home visit (with the patient) or an environ-
mental visit (without the patient). Rehabilitation and
ongoing care provided by a specialist ESD team begins
immediately after discharge. The duration and intensity
of ESD therapy depends upon patient need. The discharge
policy of ESD services varies, with some services defining
a maximum period of input of three months. ESD teams
do not usually retain any contact or involvement with pa-
tients once their input has ceased. Following discharge
from ESD services, the concept of organised stroke care
disappears. Patients who have ongoing rehabilitation needs
may be referred to a range of services, most of which
do not offer specialist stroke rehabilitation, such as
neurorehabilitation teams, day hospitals and community
rehabilitation services. This research study is evaluating an
extended stroke rehabilitation service which commences
when ESD ends. The service is delivered by existing ESD
teams and extends organised stroke care beyond ESD.
Methods/design
Study aim and objectives
This study aims to determine the clinical and cost effect-
iveness of an extended stroke rehabilitation service. The
objectives of the study are as follows:
1. To determine whether an extended stroke
rehabilitation service (intervention) improves patient
outcomes compared to usual care (control). The
primary outcome is extended activities of daily living
(EADL) at 24 months following randomisation.
Secondary outcomes are: health status, quality of life,
mood and experience of services (12 and 24 months
following randomisation).
2. To determine whether an extended stroke
rehabilitation service improves carer outcomes
compared to usual care. Outcomes are: quality of
life, carer stress and experience of services (12 and
24 months following randomisation).
3. To determine the cost effectiveness of an extended
stroke rehabilitation service.
4. To document how the extended stroke rehabilitation
service is implemented and delivered in different
settings.
5. To seek the views and experiences of patients, carers
and rehabilitation staff about the community
rehabilitation they have received or provided.
6. To explore the impact of the severity of activity
limitation, pre-stroke heath status and comorbidity
upon the effectiveness of the intervention.
Study design
This study is a pragmatic, observer-blind, parallel group,
multicentre, randomised controlled trial with health
economic and process evaluations. Figure 1 summaries
the study methods.
Study setting
The study is being conducted in National Health Service
(NHS) stroke services that provide ESD. To be eligible to
take part, ESD services must meet the following criteria:
1. The ESD service is a multidisciplinary stroke team
who provide community rehabilitation following
discharge from hospital.
2. The ESD service provides stroke rehabilitation at
home within 48 hours of patient discharge from
hospital.
Rodgers et al. Trials  (2015) 16:205 Page 2 of 10
3. The ESD service provides stroke rehabilitation for a
specified period of time and/or has clear criteria for
discharge of patients from the service.
Study participants
Adults who have experienced a stroke and who fulfil the
following criteria are eligible:
Inclusion criteria
1. Aged 18 years and over,
2. Confirmed diagnosis of new stroke (first ever or
recurrent),
3. Will be discharged from hospital under the care of
an ESD team or are currently receiving this service.
Exclusion criteria
1. Unable to participate in a rehabilitation programme
which focuses upon EADL
A carer is the main family member or friend, who will
provide support after discharge. He or she may not ne-
cessarily be co-resident with the patient. If a stroke pa-
tient has no carer or a carer does not wish to participate
Target population
510 stroke patients and carers (where appropriate) receiving early supported discharge (ESD). 
Recruitment and consent
Potentially eligible patients identified prior to discharge from hospital or during routine ESD care. Study discussed 
and patient information sheet given. Written informed consent obtained. 
Recruitment assessment
Recruitment assessment performed prior to discharge from hospital or during routine ESD care. 
Baseline assessment
Baseline assessment performed prior to discharge from ESD service. 
Central randomisation
Newcastle University Clinical Trials Unit 
Control Group 
Usual care 
Participants receive usual care following completion of 
rehabilitation by an early supported discharge team.   
Intervention Group 
Extended stroke rehabilitation service 
Participants receive the extended stroke rehabilitation 
service following completion of rehabilitation by an early 
supported discharge team (ESD).  Ongoing rehabilitation 
will be led and coordinated by a senior ESD team member 
with review at 1, 3, 6, 12 and 18 months.  
12 month assessment
Patient assessment: Carer assessment: 
Extended activities of daily liv QE(efilfoytilauQ)LDAEN(gni -5D) 
ertSreraC)SHO(sutatshtlaeH ss (Caregiver Strain Index) 
Quality of life (EQ-5D) Experience of Services  
)DAH(tnemssessadooM
secivresfoecneirepxE
Adverse events 
Resource utilisation  
24 month assessment
Outcome measures as above 
Qualitative interviews with sample of patients, carers and rehabilitation staff 
Figure 1 Study summary. ESD: Early Supported Discharge. NEADL: Nottingham Extended Activities of Daily Living Scale. OHS: Oxford Handicap
Scale. HAD: Hospital Anxiety and Depression Scale.
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in the study, the patient may still participate in the
study.
Case ascertainment, recruitment and consent
Patients
Potential patients are identified and recruited by NHS
staff (clinicians, staff from the Local Clinical Research
Network (LCRN) and senior members of the ESD team)
at each participating NHS centre. Potential patients may
be recruited prior to discharge from hospital or whilst
receiving care from an ESD service. Although the extended
stroke rehabilitation service does not commence until rou-
tine ESD services end, identification and recruitment of
patients in hospital or during ESD maximises recruitment
opportunities.
Consent for patients with mental capacity
For potential participants with mental capacity to con-
sent to research, NHS staff approach the patient, discuss
the study and provide a study information sheet. After
allowing sufficient time for potential participants to de-
cide whether to take part in the study (over 24 hours)
and an opportunity to ask questions, consent is obtained
in writing. Where a patient has mental capacity but is
unable to sign the consent form (for example, because of
weakness of the dominant hand following stroke), con-
sent is confirmed orally in the presence of a witness (an
individual not otherwise involved in the trial), who signs
the consent form on behalf of the participant.
Consent for patients with aphasia
In order to include stroke patients with communication
difficulties due to aphasia in this study, a set of ‘easy
access’ study documentation was specifically developed.
To recruit and consent patients with aphasia, NHS staff
approach the patient, discuss the study and provide
them with the easy access information sheet. After
allowing sufficient time for the information to be consid-
ered (over 24 hours) and an opportunity to ask questions,
consent is obtained in writing using the easy access
consent form.
Consent for patients without mental capacity
Stroke patients who do not have mental capacity can also
take part in this study. As patients with mental incapacity
often have more disabling strokes, we believe that they may
benefit from the extended stroke rehabilitation service. To
recruit patients lacking in mental capacity, NHS staff iden-
tify a personal consultee to approach and discuss the study
with. This is a person who is in a position to advise on the
wishes and feelings of the potential patient in relation to
taking part in this research project. The identified consultee
is provided with a consultee information sheet. After allow-
ing sufficient time to consider the patient’s wishes and
feelings (over 24 hours) and an opportunity to ask ques-
tions, the consultee is asked to complete a consultee declar-
ation form if they believe the patient would have no
objection to taking part in the study.
If a patient regains capacity during their participation
in the study, they will be informed about the study, given
a ‘recovered capacity’ patient information sheet and
asked to provide their own consent to continue in the
study on a recovered capacity consent form. If a patient
does not wish to continue in the study, they will be with-
drawn. Data collected prior to withdrawal will be used in
the study analysis.
Due to the nature of this study, potential patients lack-
ing in capacity also need to have a relative or friend
(carer) who is prepared to assist with the extended
stroke rehabilitation service reviews and outcome assess-
ments, as these are unlikely to be possible without their
support.
Loss of capacity to consent to research during participation
in the study
If a patient who has provided their own consent loses
capacity to consent to research during their participation
in the study, advice will be sought from a personal con-
sultee about their continuing participation in the study.
This will be a person who is in a position to advise on
the wishes and feelings of the patient in relation to the
research study. On entering the study, patients are asked
to nominate a relative or friend who they would like to
be their consultee should they lose capacity to consent
to research. In the event of loss of capacity to consent to
this research, the nominated consultee will be given a
‘loss of capacity’ consultee information sheet. If a con-
sultee believes the patient would have no objection to
continuing in the study, they will be asked to complete a
loss of capacity consultee declaration form. If the con-
sultee believes that the patient would not wish to continue
in the study, the patient will be withdrawn from the study.
Data collected prior to withdrawal will be used in the
study analysis.
Carers
Potential carers are identified by ESD senior team mem-
bers whilst the patient is receiving routine ESD care. At
the time of patient discharge from routine ESD services,
if the patient has an identified carer, he or she is pro-
vided with an invitation letter, study information sheet,
study carer baseline questionnaire and pre-paid envelope
(addressed to the study coordinating centre). Provision
of the invitation letter and study documents may be in
person by an ESD senior team member, by post by the
local study team or by a consented patient. These three
options are used to maximise potential opportunities for
carers to take part in the study as carers are not always
Rodgers et al. Trials  (2015) 16:205 Page 4 of 10
present at staff visits. The invitation letter asks a carer to
complete and return the baseline questionnaire, if he or
she is willing to participate in the study.
Recruitment assessment
A patient recruitment assessment is performed by NHS
staff after informed consent has been obtained and
within four days prior to planned discharge from hos-
pital, or during routine ESD care. The following data are
collected: demographic data, pre-stroke level of EADL
(Nottingham EADL Scale [11]), pre-stroke health status
(Oxford Handicap Scale [12]), date of hospital admission,
date of stroke, stroke type and subtype, National Institute
of Health Stroke Scale (NIHSS) [13], comorbidity and
pre-stroke resource usage (adaptation of the Client Service
Receipt Inventory (CSRI) [14-16]).
Baseline assessment
A patient baseline assessment is performed by NHS staff
at discharge from routine ESD services and immediately
prior to randomisation. The following data is collected:
date of hospital discharge, date of ESD discharge, Abbrevi-
ated Mental Test Score [17], Sheffield Aphasia Screening
Test [18], EADL (Nottingham EADL Scale [11]), health sta-
tus (Oxford Handicap Scale [12]), quality of life (EuroQol
EQ-5D [19]) and mood (Hospital Anxiety and Depression
Scale [20]).
Carers receive a baseline questionnaire with the study
invitation letter. The questionnaire collects the following
data: demographic data, quality of life (EuroQol EQ-5D
[19]) and carer stress (Caregiver Strain Index [21]).
Randomisation
Randomisation is by a central independent web-based
service hosted by Newcastle University Clinical Trials
Unit. Participants are stratified according to stroke service
and randomised to either the intervention or control
group in a 1:1 ratio using permuted block sequences.
Stroke patients and carers are randomised as a single unit.
Study control treatment
Usual care and provision of booklet about stroke care and
rehabilitation
Stroke patients in the control group receive usual ESD care
with subsequent referral to other rehabilitation services
post-discharge from ESD if required and in accordance
with usual care. Patients who have ongoing rehabilitation
needs following completion of ESD may be referred to a
range of services such as neurorehabilitation teams, day
hospitals and community rehabilitation services.
In addition, both control and intervention group partici-
pants receive the booklet ‘Care after stroke or transient is-
chaemic attack. Information for patients and their carers’,
written by the Intercollegiate Stroke Working Party [22].
It describes what a stroke is, assessment, acute manage-
ment and rehabilitation. It is based on the National
Clinical Guideline for Stroke [6].
Study intervention treatment
Extended stroke rehabilitation service and provision of
booklet about stroke care and rehabilitation
Stroke patients in the intervention group receive an
extended stroke rehabilitation service for 18 months
following completion of rehabilitation with their ESD
team. This is in addition to usual care. They also re-
ceive the Intercollegiate Stroke Working Party booklet
about stroke care and rehabilitation.
The extended stroke rehabilitation service consists of
reviews by a designated senior member of the ESD team
at 1, 3, 6, 12 and 18 months post-discharge from routine
ESD. We have chosen to evaluate a model where care is
coordinated rather than delivered by a senior member of
the ESD team, as this model could potentially be deliv-
ered by the National Health Service (NHS) throughout
the UK, if shown to be effective. The role of specialists
coordinating rather than delivering rehabilitation has
been shown to be effective in other conditions [23].
Each review consists of:
1. A semi-structured interview to identify the patient’s
progress, current rehabilitation needs and service
provision. The interview addresses everyday activities
(personal care, meal times, domestic activities, indoor
mobility, outdoor mobility, shopping, hobbies and
driving), social participation and wider issues
(mood, memory, pain, communication and medical
issues) which may be problematic for stroke survivors.
The views of both the patient and carer (where
appropriate) are sought.
2. Joint rehabilitation goal setting. From the identified
progress and rehabilitation needs, up to five individual
rehabilitation goals are set by the patient (and carer) in
collaboration with the senior ESD team member who
conducts the review. The focus of joint goal setting is
upon increasing participation in everyday activities.
The physical, psychological and social factors which
may impact on goal attainment are considered. At each
review, progress towards goals from the previous
review is assessed prior to further goal setting.
Achievement of goals is recorded using a Goal
Attainment Scale [24].
3. Action planning. The patient (and carer) agree an
action plan for each rehabilitation goal. This may
include:
 Verbal advice and encouragement;
 Discussion with the stroke team, rehabilitation
team, primary care team or social services
involved in care;
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 Signposting to local activities, community
organisations or voluntary services;
 Referral to stroke services, rehabilitation services
or primary care services for further assessment
and treatment, if required, according to local
guidelines and/or service provision.
The majority of the reviews are intended to be done
by telephone. The senior ESD team member will know
the patient and carer as he or she will have treated the
patient as part of the ESD service. However, if the pa-
tient and/or carer is unable to participate in a telephone
review, a home visit can be undertaken. Patients are
given a study appointment card which also contains a
short checklist of rehabilitation issues to be covered in
each review. This is to allow patients (and carers) time
to consider the topics to be discussed prior to the inter-
view. Patients with aphasia receive an easy access version
of the appointment card.
All senior ESD staff taking part in the trial receive an
extended stroke rehabilitation service manual and train-
ing in delivery of the new service. The extended stroke
rehabilitation manual describes how to conduct the re-
views, including guidance on exploring rehabilitation
needs, goal setting and appropriate interventions to meet
a patient’s needs.
Subsequent to each review the ESD therapist or nurse
may contact services currently involved in the patients
care to discuss progress, goals and care plan.
A summary of the review and recommendations for
rehabilitation is sent to the patient, patient’s GP, stroke
physician and therapists currently involved in the pa-
tient’s care. Patients with aphasia receive an easy access
version of the letter.
Outcome assessments
Outcomes are assessed at 12 months (+/− 7 days) and
24 months (+/− 7 days) following randomisation.
Patient outcome assessments are undertaken by tele-
phone by a researcher based in the study coordinating
centre. For participants who do not have a telephone or
who are unable to communicate by telephone, outcomes
are collected by postal questionnaire. If a patient is unable
to participate in a telephone interview or complete a pos-
tal questionnaire, outcome assessments are undertaken by
local staff trained by the study team.
The following data is collected from patients: EADL
(Nottingham EADL Scale [11]), health status (Oxford
Handicap Scale [12]), quality of life (Euroqol EQ-5D
[19]), mood (Hospital Anxiety and Depression Scale
[20]), experience of services (adaption of an experience
survey designed by Northumbria Healthcare NHS
Foundation Trust) and resource utilisation (adaptation
of the CSRI [14-16]).
Carers’ outcome assessments are undertaken by pos-
tal questionnaire. This is because the Caregiver Strain
Index asks some sensitive questions about the impact of
stroke upon the carer [21]; a carer may modify their an-
swer if they could be overheard on the telephone by the
patient. The carer outcome questionnaire collects the fol-
lowing data: quality of life (EuroQoL EQ-5D [19]), carer
stress (Caregiver Strain Index [21]) and experience of
services (adaption of an experience survey designed by
Northumbria Healthcare NHS Foundation Trust).
Blinding
Due to the nature of the intervention, it is not possible
to blind stroke patients or carers to treatment allocation.
Where patient outcome assessments are undertaken by
telephone or face to face, it is intended that they are
conducted blinded to treatment allocation. After each
assessment the assessor is asked to record whether they
have unintentionally become aware of treatment alloca-
tion due to conversation with the participant. Success of
patient outcome assessment blinding will be reported.
Study withdrawal
No specific study withdrawal criteria have been pre-set.
Stroke patients and/or carers may withdraw from the
study at any time for any reason. Data collected prior to
withdrawal will be used in the study analysis unless
consent for this is specifically withdrawn. Reasons for
withdrawal are sought, but patients and/or carers can
chose to withdraw without providing an explanation.
Investigators, senior ESD team members and/or a patient’s
consultee (in the case of mental incapacity) may also with-
draw participants from the study at any time if they feel it
is no longer in their interest to continue, for example,
because of intercurrent illness or adverse events.
Safety evaluation
The safety of the extended stroke rehabilitation service is
being evaluated by examining the occurrence of all ad-
verse events and serious adverse events in accordance with
National Research Ethics Committee (NRES) guidance.
Statistical analysis
Primary analysis
The primary outcome is the Nottingham EADL score
[11] at 24 months. Analysis will be on the basis of
intention to treat. Mean scores will be compared be-
tween intervention and control groups using multiple
linear regression, including terms for sites and patient-
level covariates such as baseline scores.
Secondary analyses
Secondary outcomes will be compared between interven-
tion and control groups using multiple linear regression,
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including terms for sites and patient-level covariates such
as baseline scores. Further exploratory descriptive analyses
will examine the impact of the severity of activity limita-
tion, pre-stroke health status and comorbidity upon the
effectiveness of the intervention; there is not sufficient
power to perform any formal subgroup analyses.
Sample size
There is consensus that a difference of 6 points (range: 0
to 66, standard deviation (SD): 18) on the Nottingham
EADL Scale is clinically important, and power calcula-
tions for previous multicentre rehabilitation trials have
been based upon this difference [16,25]. Responses from
382 patients split equally between intervention and control
groups will provide 90% power to detect a difference in
mean Nottingham EADL score of 6 points. Based on attri-
tion in other stroke rehabilitation trials, we believe that
there may be up to 25% attrition between study randomisa-
tion and the 24-month (primary) outcome assessment. To
allow for this, we aim to randomise 510 participants into
the study.
Although participants may be recruited any time from
within four days prior to discharge from hospital until
discharge from ESD, many are likely to be recruited
prior to discharge from hospital. There may be several
weeks between recruitment and randomisation, and
some participants may withdraw from the study during
this time. Our current estimate is that up to 15% may
drop out before randomisation. The target recruitment
sample size is being kept under review, and recruitment
will cease when we estimate that 510 participants will be
randomised. Reasons for loss from the trial are recorded.
Economic analysis
The economic evaluation will include both a cost-
effectiveness analysis (CEA) and a cost-utility analysis
(CUA) [26]. The CEA will be undertaken using the Not-
tingham EADL Scale [11] at 24 months as the measure
of effect. The result of the CEA will be an incremental
cost-effectiveness ratio (ICER) [27]. In order to quantify
the uncertainty associated with the ICER, the stochastic
analysis will be conducted, with the results presented as
a cost-effectiveness acceptability curve (CEAC) [28]. The
CEAC will show the probability that an extended stroke
rehabilitation service is cost effective compared with
usual post-ESD care, given the observed data, for a range
of maximum monetary values that decision-makers may
be prepared to pay for unit change in Nottingham EADL
Scale [11]. The CUA will compare changes in health-
related quality of life, based on responses to the EuroQoL
EQ-5D [19], at baseline and 24 months across both arms
of the trial. These data will be combined with study partic-
ipant’s mortality to estimate quality-adjusted life years
(QALYs). Both costs and QALY data will be combined
into an incremental cost per QALY. Both analyses will be
carried out from the perspective of the NHS, but we will
also take societal perspective by including costs borne by
the participants themselves and their informal carers by
obtaining information about time away from employment
and time spent providing care.
Resource utilisation will be assessed at 12 and
24 months using an appropriate adaptation of the CSRI
[14-16]. We will identify all the relevant financial costs
associated with providing the intervention. Relevant
costs will be categorised as either fixed costs or variable
costs, where fixed costs are those resources that are re-
quired to set up and run the service and variable costs
are those required to treat an individual patient. Where
appropriate, discounting [26] will be applied to financial
costs and outcomes. Financial costs will be attached to the
items of service used using data from the Personal Social
Services Research Unit [29]. Because the consequences of
an extended stroke rehabilitation service may extend
beyond the 24-month timeframe of the trial, and may have
on-going significant financial cost and quality of life impli-
cations (for example, a reduced incidence of hospitalisa-
tion related to falls or need for residential or nursing
home care), a Markov model will be developed that can be
used to predict outcomes up to 60 months based on the
status at 24 months. Transition probabilities and cost
associated with each state in the model will be obtained
from published literature and, where no published evi-
dence exists, expert opinion will be sought. Other forms
of uncertainty such as variation in unit prices will be
explored within the deterministic sensitivity analyses;
where appropriate these CEACs will also be produced
for these analyses.
Parallel process evaluation
Parallel process evaluations of complex interventions
being tested by randomised controlled trials are increas-
ingly recommended [30]. They can provide information
about unanticipated consequences, reasons for success,
how an intervention can be improved and identify con-
textual factors associated with variations in outcome [31].
This process evaluation is investigating the operation of
the extended stroke rehabilitation service collecting both
quantitative and qualitative data. This includes:
1. Mapping the rehabilitation and follow-up services
provided for stroke patients in each site.
2. Documenting how the new service is implemented
and delivered in different settings. A senior ESD
team member at each site completes a standard pro
forma at each assessment. This consists of a
progress update, rehabilitation undertaken since the
previous assessment, services received and progress
toward rehabilitation goals. The patient’s current
Rodgers et al. Trials  (2015) 16:205 Page 7 of 10
rehabilitation needs, assessment and advice given to
the patient and carer are recorded. Details of new
referrals to other services are also recorded.
3. Seeking the views and describing the experiences of
patients and carers about the rehabilitation services
they received. Semi-structured interviews will be
conducted with a purposive sample of patients and
caregivers who received the extended stroke
rehabilitation service and usual care. Sampling will use
variables of age, gender, level of disability and
geographical location of research sites for
participant selection. Equal numbers of control and
intervention group participants will be selected to
allow comparison between the two groups. A topic
guide has been devised drawing on relevant literature
[32-35]. The interviews include questions on views
and perceptions about ability to undertake EADL,
enablers and barriers, perceptions of provision of
rehabilitation to support EADL and perceptions of
unmet need. Interviews will take place after final
outcome assessment. The topic guide will be refined
by pilot interviews with a small sample (approximately
four) of patients and their carers. The guide will then
be used with up to 60 patients and/or patient/carer
dyads, with final numbers determined when data
saturation is considered to have been achieved
through ongoing analysis [36]. All interviews will
be digitally recorded, transcribed and entered onto
NVivo (QSR International, Melbourne, Australia)
for data management.
4. Seeking the views and experiences of senior members
of the ESD teams and community rehabilitation staff
about the services provided to the intervention and
control groups. Semi-structured interviews will be
conducted with a purposive sample of
rehabilitation staff who were involved in the study.
Sampling will ensure the involvement of the range
of healthcare professionals delivering the intervention.
A topic guide will be developed following a small pilot
sample of unstructured interviews with two senior
ESD team members who provided the extended stroke
rehabilitation service and two members of community
rehabilitation services. Interviews will investigate
their experience in delivering rehabilitation to
improve EADL, the longer term needs relating to
the EADL of people with stroke and their carers,
and views about the extended stroke rehabilitation
service compared to usual care. Interviews will
then be undertaken with two to three members of
the community teams in all study sites. Since
interviews conducted during the trial may have
the undesired effect of changing staff practice,
these will be undertaken within six weeks of the
end of delivery of the trial intervention.
Interview data analysis
Transcribed interviews will be checked and corrected for
errors by the interviewer. Analysis will follow standard
approaches that entail familiarisation with the material,
coding and category development to identify the main pat-
terns of responses, consistencies and divergences across
and within interviews, and to identify similarities and
differences between and within group testing [37]. Com-
mon experiences, outlier views and significant differences
by category of respondent will be identified. A sub-sample
of interview data will be independently analysed by a study
co-investigator, and compared to the analysis undertaken
by the interviewer.
We will use accepted approaches to demonstrating
rigour in qualitative research [38], including clear docu-
mentation of research methods and processes, transpar-
ency in the use of data collection schedules, independent
coding and analysis by researchers, systematic exploration
of alternative explanations for the processes claimed to ex-
plain our findings and, as far as possible, the involvement
of study participants in a discussion of the initial analyses.
Ethics and regulatory issues
The study sponsor is Northumbria Healthcare NHS
Foundation Trust. The study is being conducted in ac-
cordance with Research Governance Framework for
Health and Social Care [39]. Ethical approval was
granted by the National Research Ethics Committee
North East - Newcastle and North Tyneside 1 (reference
12/NE/0217). NHS Trust approvals have also been
granted from Northumbria Healthcare NHS Foundation
Trust, Leeds Teaching Hospitals NHS Trust, Leeds
Community Healthcare NHS Trust, Newcastle upon
Tyne Hospitals NHS Foundation Trust, Pennine Acute
Hospitals NHS Trust, Pennine Care NHS Foundation
Trust, South Tyneside NHS Foundation Trust, Royal
Cornwall Hospitals NHS Trust, Solent NHS Trust,
Portsmouth Hospitals NHS Trust, Plymouth Community
Healthcare, Norfolk Community Health and Care NHS
Trust, Staffordshire and Stoke on Trent Partnership NHS
Trust, Royal Bournemouth and Christchurch Hospitals
NHS Foundation Trust, Hull and East Yorkshire Hospitals
NHS Trust, Humber NHS Foundation Trust, York
Teaching Hospital NHS Foundation Trust, Sherwood
Forest Hospitals NHS Foundation Trust, Somerset Part-
nership NHS Trust, Wrightington, Wigan and Leigh NHS
Foundation Trust and Cardiff and Vale University
Health Board.
Discussion
The provision of longer term support for stroke survivors
and their families is currently limited. Well-designed rando-
mised controlled trials are required to provide an evidence
base to inform development of community stroke services.
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The EXTRAS trial is a large, multicentre, randomised con-
trolled trial to evaluate an extended stroke rehabilitation
service which begins once ESD is completed. The results
from the trial will inform future stroke service planning
and configuration.
Trial status
The EXTRAS trial commenced recruitment in November
2012. It is currently running in 18 NHS study centres. One
or more centres are open in North East England, North
West England, Yorkshire, Midlands, East England, South
East England, South West England and Wales. The
EXTRAS trial has recruited 541 patients at the time of
submission of this manuscript (February 2015). Re-
cruitment is scheduled for completion in summer
2015. Follow-up will continue until 2017. Results will
be submitted for publication in 2018.
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